Organization Profile

Cipher Pharmaceuticals Inc.

Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval...

You just read:

Cipher Pharmaceuticals Receives Health Canada Approval of Xydalba™ (dalbavancin hydrochloride)

News provided by

Cipher Pharmaceuticals Inc.

Sep 10, 2018, 16:00 ET